ACADEMIC & INDUSTRY INTERSECTION CONFERENCE · creation. The conference will close with a...
1
ACTSi community discovery training Georgia as a Biotechnology Capital? April 14, 2016 9:00 a.m. to 1:30 p.m. Emory Conference Center Hotel Starvine Ballroom 1615 Clifton Road NE Atlanta, GA 30329 Register Now Register Now Emory, Morehouse School of Medicine, and Georgia Tech faculty, staff, and students $20 Georgia Bio Members $30; Non-Members $60 www.gabio.org Keynote Speakers C. Michael Cassidy, President & CEO, Georgia Research Alliance (GRA) Cassidy will provide a local state-of-affairs on Georgia’s biotechnology past, present, and future to begin open dialogue and motivate change. As the leader of GRA for 16 years, he will deliver clear insight on the state’s journey as a biotechnology capital. While sharing his vision for the state, celebrating our strengths, and defining our weaknesses. His experience and understanding of city and state politics will res-onate and enlighten the expert audience. Kenneth I. Moch, Managing Partner, Salutramed Group Moch will offer a regional and national perspective and discuss the current and future biotechnology climate. He will share best practices and advice for Georgia to become a biotechnology capital using his broad expertise building, managing, and financing private and public life sciences companies from start-up through commercialization, and creation of five companies which have pioneered novel technologies. What is the purpose? ACTSI (Atlanta Clinical & Translational Science Institute), led by Emory University with partners Morehouse School of Medicine and Georgia Institute of Technology, and Georgia Bio, the state’s life sciences industry association, organize this conference annually. This year’s conference will explore Georgia’s biotechnology climate, venture capital innovation, and feature an expert panel highlighting commercialization training options throughout the state. Interested in Sponsoring the Conference? Contact: Elizabeth Thompson, [email protected], 404-727-2579 ACADEMIC & INDUSTRY INTERSECTION CONFERENCE
Transcript of ACADEMIC & INDUSTRY INTERSECTION CONFERENCE · creation. The conference will close with a...
ACTSicommunity discovery training
Georgia as a Biotechnology Capital?
April 14, 2016
9:00 a.m. to 1:30 p.m.
Emory Conference
Center Hotel
Starvine Ballroom
1615 Clifton Road NE
Atlanta, GA 30329
Register Now
Register Now
Emory, Morehouse School of Medicine, and Georgia Tech faculty, staff, and students $20
Georgia Bio Members $30; Non-Members $60
www.gabio.org
Keynote SpeakersC. Michael Cassidy, President & CEO, Georgia Research Alliance (GRA)
Cassidy will provide a local state-of-affairs on Georgia’s biotechnology past, present, and future to begin open dialogue and motivate change. As the leader of GRA for 16 years, he will deliver clear insight on the state’s journey as a biotechnology capital. While sharing his vision for the state, celebrating our strengths, and defining our weaknesses. His experience and understanding of city and state politics will res-onate and enlighten the expert audience.
Kenneth I. Moch, Managing Partner, Salutramed Group Moch will offer a regional and national perspective and discuss the current and future biotechnology climate. He will share best practices and advice for Georgia to become a biotechnology capital using his broad expertise building, managing, and financing private and public life sciences companies from start-up through commercialization, and creation of five companies which have pioneered novel technologies.
What is the purpose?ACTSI (Atlanta Clinical & Translational Science Institute), led by Emory University with partners Morehouse School of Medicine and Georgia Institute of Technology, and Georgia Bio, the state’s life sciences industry association, organize this conference annually. This year’s conference will explore Georgia’s biotechnology climate, venture capital innovation, and feature an expert panel highlighting commercialization training options throughout the state.
Interested in Sponsoring the Conference? Contact: Elizabeth Thompson, [email protected], 404-727-2579
ACADEMIC & INDUSTRY INTERSECTION CONFERENCE
ACADEMIC & INDUSTRY INTERSECTION CONFERENCE
6th Annual Academic & Industry Intersection Conference Innovative Investment Models
Thursday, April 30, 2015
9:00 a.m.-1:30 p.m.
Morehouse School of Medicine
Louis W. Sullivan National Center
for Primary Care Auditorium
720 Westview Drive SW
Atlanta, GA 30310
Register Now
Register Now Emory, Morehouse School of Medicine, and Georgia Tech faculty, staff, and students $20
Georgia Bio Members $30; Non-Members $60
www.gabio.org/event/actsi2015
Keynote Speaker Pablo Legorreta, Royalty Pharma, Founder & CEORoyalty Pharma recently bought drug rights on Vertex Pharmaceuticals’ cystic fibrosis treatments from the Cystic Fibrosis Foundation in a deal believed to be the largest financial return ever made by any charitable organization working to find cures for medical disease. The proceeds will lead to further CF research.
What is the purpose? The Atlanta Clinical & Translational Science In-stitute (ACTSI), led by Emory University with partners Morehouse School of Medicine and Georgia Institute of Technology, and Georgia Bio, the state’s life sciences industry association, organizes this conference annually to provide critical information on how academia and industry can work together to translate science into discovery and engage communities in clinical research efforts and outcomes. The event provides a collaborative environment for university investigators and industry executives using a program filled with subject-matter experts describing current models and innovative trends shaping the future of translational science.
What will be discussed? The 6th Annual Academic & Industry Intersec-tion Conference will profile successful public-private-partnerships as well as examine how to navigate the commercialization process, followed by an expert panel featuring stories of successful academic/industry partnerships and first-hand stories of commercializing new technologies and startup creation. The conference will close with a fast-paced Shark Tank featuring faculty, student, and industry innovators presenting their technologies to investors and successful bioscience entrepreneurs and executives.
Interested in Sponsoring the Conference? Contact: Elizabeth Thompson, [email protected], 404-727-2579
Thursday, April 30, 2015
she wants you to add the Emory, Ga Tech, and Morehouse logos to this somewhere. Do you have them and is there room?
ACADEMIC & INDUSTRY INTERSECTION CONFERENCE
6th Annual Academic & Industry Intersection Conference Innovative Investment Models
Thursday, April 30, 2015
9:00 a.m.-1:30 p.m.
Morehouse School of Medicine
Louis W. Sullivan National Center
for Primary Care Auditorium
720 Westview Drive SW
Atlanta, GA 30310
Register Now
Register Now Emory, Morehouse School of Medicine, and Georgia Tech faculty, staff, and students $20
Georgia Bio Members $30; Non-Members $60
www.gabio.org/event/actsi2015
Keynote Speaker Pablo Legorreta, Royalty Pharma, Founder & CEORoyalty Pharma recently bought drug rights on Vertex Pharmaceuticals’ cystic fibrosis treatments from the Cystic Fibrosis Foundation in a deal believed to be the largest financial return ever made by any charitable organization working to find cures for medical disease. The proceeds will lead to further CF research.
What is the purpose? The Atlanta Clinical & Translational Science In-stitute (ACTSI), led by Emory University with partners Morehouse School of Medicine and Georgia Institute of Technology, and Georgia Bio, the state’s life sciences industry association, organizes this conference annually to provide critical information on how academia and industry can work together to translate science into discovery and engage communities in clinical research efforts and outcomes. The event provides a collaborative environment for university investigators and industry executives using a program filled with subject-matter experts describing current models and innovative trends shaping the future of translational science.
What will be discussed? The 6th Annual Academic & Industry Intersec-tion Conference will profile successful public-private-partnerships as well as examine how to navigate the commercialization process, followed by an expert panel featuring stories of successful academic/industry partnerships and first-hand stories of commercializing new technologies and startup creation. The conference will close with a fast-paced Shark Tank featuring faculty, student, and industry innovators presenting their technologies to investors and successful bioscience entrepreneurs and executives.
Interested in Sponsoring the Conference? Contact: Elizabeth Thompson, [email protected], 404-727-2579
Thursday, April 30, 2015
she wants you to add the Emory, Ga Tech, and Morehouse logos to this somewhere. Do you have them and is there room?
